Solutions to Enable Regional Genomic Medicine eConsult Services (R41/R42 Clinical Trial Optional)
ID: PAR-24-107 • Type: Posted
Overview
Category of Funding
Health
Funding Instruments
Grant
Grant Program (CFDA)
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 1/9/24 the National Institutes of Health posted grant opportunity PAR-24-107 for Solutions to Enable Regional Genomic Medicine eConsult Services (R41/R42 Clinical Trial Optional).
The grant will be issued under grant program 93.172 Human Genome Research.
Timing
Posted Date
Jan. 9, 2024, 12:00 a.m. EST
Closing Date
May 30, 2024, 12:00 a.m. EDT Past Due
Last Updated
Jan. 9, 2024, 2:31 p.m. EST
Version
1
Archive Date
July 5, 2024
Eligibility
Eligible Applicants
Small businesses
Additional Info
Other Eligible Applicants include the following:
Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Contacts
Contact
National Institutes of Health
Contact Email
Email Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Contact Phone
(301) 402-2541
Additional Information
https://grants.nih.gov/grants/guide/pa-files/PAR-24-107.html
Additional Information Site